Nektar Therapeutics
NKTRBiotechnology
$38.87−0.79%As of Oct 30vs prior close
- Market cap
- $1.3B
- P/E (TTM)
- –
- From 52W high
- −61.27%
- EPS (LTM)
- -$6.21
- Revenue (LTM)
- $54.6M
- Net margin
- -287.84%
- Dividend yield
- 0.00%
Nomior Score
36
Steady ProfileSpeculativeBottom 22% of the scored universe
Growth45
Quality47
Value42
Momentum41
Resilience37
Growth
−11.48%revenue a year over 9 fiscal years
YE16 $165.4MLTM $54.6M
Connections
Revenue to profitQ2 YE26
The operating loss was 418% of revenue, wider by 94 pts on a year.
Who owns it
2funds